Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02033824 · ClinicalTrials.gov registry record · NA
Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02033824: Completed NA study, sponsored by MiMedx Group.
NCT02033824 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02033824, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of dHACM in reducing scar tissue formation in craniectomy patients as well as facilitating reoperation and repair. Specifically this study compares craniectomy without dHACM application to craniectomy with placement of dHACM between the galea and dura over dural suture line and/or exposed parenchyma.
Interventions
- OTHER dHACM
- PROCEDURE Craniectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-06 |
| Phase | NA |
What the finished NCT02033824 record still lists
NCT02033824 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which dHACM is the first listed.
NCT02033824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02033824 about?
NCT02033824 is a clinical study titled "Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring". The purpose of this study is to evaluate the effectiveness of dHACM in reducing scar tissue formation in craniectomy patients as well as facilitating reoperation and repair. Specifically this study compares craniectomy without dHACM application to craniectomy with placement of dHACM between the gale...
What is the current status of trial NCT02033824?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-04. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02033824?
The interventions under investigation include: dHACM (OTHER), Craniectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02033824?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02033824's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia